Rani Therapeutics Holdings (RANI) Asset Utilization Ratio (2021 - 2026)
Rani Therapeutics Holdings (RANI) posted quarterly Asset Utilization Ratio of 0.06 for Q1 2026, up 45.21% year-over-year from 0.04 in Q1 2025, and up 20.76% quarter-over-quarter from 0.05 in Q4 2025.
Rani Therapeutics Holdings (RANI) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.06 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 45.21% year-over-year to 0.06; the TTM figure through Mar 2026 stood at 0.06 (up 45.21% YoY), while the FY2025 annual figure was 0.03, up 57.68% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.06, up from 0.05 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.09 in Q3 2025, with the low at 0.02 in Q2 2022.
- The 4-year median for Asset Utilization Ratio is 0.05 (2025), against an average of 0.05.
- The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio jumped 85.22% in 2025, then jumped 45.21% in 2026.
- Rani Therapeutics Holdings' Asset Utilization Ratio stood at 0.02 in 2022, then jumped by 43.62% to 0.03 in 2024, then surged by 85.22% to 0.05 in 2025, then grew by 20.76% to 0.06 in 2026.
- Business Quant data shows RANI's Asset Utilization Ratio at 0.06 in Q1 2026, 0.05 in Q4 2025, and 0.09 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.13 |
| 10 | Rani Therapeutics Holdings | 164.82 Mn | 164.82 Mn | - | 0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.09 |
| Mar 31, 2026 | 0.06 |
| Dec 31, 2025 | 0.05 |
| Sep 30, 2025 | 0.09 |
| Jun 30, 2025 | 0.06 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | 0.03 |
| Jun 30, 2022 | 0.02 |
| Dec 31, 2021 | 0.02 |
| Sep 30, 2021 | 0.03 |